Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats-Reference-Cited by-同舟云学术

Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats

Published:2023-08 Issue: Volume:952 Page:175754
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li Qian,Fang Yuan,Peng De-wei,Li Lu-an,Deng Chun-yu,Yang Hui,Kuang Su-juan,Li Qiao-qiao,Zhang Meng-zhen,Zeng Peng,Zhang Qian-huan,Liu Yang,Deng Hai,Wei Wei,Xue Yu-mei,Wu Shu-lin,Rao Fang

Funder

National Natural Science Foundation of China

Guangdong Provincial Department of Science and Technology

Guangzhou Municipal Science and Technology Project

Guangdong Provincial People's Hospital

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance;Abassi;Pharmacol. Ther.,2004

2. When it comes to defining the outcomes of catheter ablation of atrial fibrillation, an implantable monitor is a great place to start;Calkins;Circulation,2019

3. Dispersion of recovery and vulnerability to Re-entry in a model of human atrial tissue with simulated diffuse and focal patterns of fibrosis;Clayton;Front. Physiol.,2018

4. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides;D'Elia;Eur. J. Heart Fail.,2017

5. Upstream therapy for atrial fibrillation prevention: the role of sacubitril/valsartan;De Vecchis;Cardiol Res,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction;Pharmacological Research;2024-06

2. Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system;Biomedicine & Pharmacotherapy;2024-04

3. Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease;Biomedicines;2024-03-25

4. Sacubitril/valsartan attenuates atrial conduction disturbance and electrophysiological heterogeneity with ameliorating fibrosis in mice;Frontiers in Cardiovascular Medicine;2024-01-19

5. Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats;Biomedicine & Pharmacotherapy;2024-01